DermTech, Inc. Profile Avatar - Palmy Investing

DermTech, Inc.

DermTech, Inc., a molecular diagnostic company, develops and markets novel non-invasive genomics tests to diagnosis skin cancer, inflammatory diseases, and aging-related conditions in the United States. It offers DermTech Melanoma Test (DMT), a gene expr…

Medical - Diagnostics & Research
US, La Jolla [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

Not a single 10-Q doc.

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of DMTK's Analysis
CIK: 1651944 CUSIP: 24984K105 ISIN: US24984K1051 LEI: - UEI: -
Secondary Listings
DMTK has no secondary listings inside our databases.